Abstract: The invention relates to a method of alleviating the symptoms of PMS and anxiety. The method comprises nasally administering a steroid which is a human vomeropherin, such that the vomeropherin binds to a specific neuroepithelial receptor. The steroid or steroids is/are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers.

Abstract: There is provided the novel compound 19-hydroxyaldosterone. There is provided a process for its preparation. There are further provided pharmaceutical compositions comprising this compound as active ingredient. These are useful, amongst others, as mineralocorticoid drugs and as drug against Addison's disease.

Abstract: The present invention relates to (2-nitro-5-aryloxyphenylamino)alkylphosphonic, -alkylphosphinic and -alkylphosphonous acid derivatives of the general formula I ##STR1## wherein X is halogen, CF.sub.3, NO.sub.2, CN, CONH.sub.2 or CSNH.sub.2,Y is nitrogen or --CH.dbd.,R is hydrogen, C.sub.1 -C.sub.4 alkyl or aralkyl containing 1 to 4 carbon atoms in the alkyl moiety,R.sub.1 is C.sub.1 -C.sub.4 alkyl,R.sub.2 is C.sub.1 -C.sub.4 alkyl, phenyl or --PO(OR.sub.6).sub.2,R.sub.3 is hydrogen or C.sub.1 -C.sub.4 alkyl,R.sub.4 is hydrogen, C.sub.1 -C.sub.4 alkyl or a cation,R.sub.5 is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 haloalkyl, C.sub.1 -C.sub.4 alkoxy, hydroxyl or an --O-cation group,R.sub.6 is hydrogen or C.sub.1 -C.sub.4 alkyl,m is a value from 0 to 3,n is 0 or 1,p is a value from 0 to 3, andq is 0 or 1,with the proviso that R.sub.1 and R.sub.3 taken together may also be an unsubstituted or substituted C.sub.1 -C.sub.